Elevated brain iron is independent from atrophy in Huntington's Disease

NeuroImage

Volumn 61, Issue 3, 2012, Pages 558-564

  Dumas, Eve M ^a   Versluis, Maarten J ^a   Van den Bogaard, Simon J A ^a   Van Osch, Matthias J P ^a   Hart, Ellen P ^a   Van Roon Mom, Willeke M C ^a   Van Buchem, Mark A ^a   Webb, Andrew G ^a   Van der Grond, Jeroen ^a   Roos, Raymund A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Disease state; Huntington's Disease; Iron; Magnetic field correlation; MRI

Indexed keywords

IRON;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN ATROPHY; BRAIN LEVEL; BRAIN REGION; BRAIN SIZE; CAUDATE NUCLEUS; CAUSAL ATTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; MALE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PREDICTION; PRIORITY JOURNAL; PUTAMEN; THALAMUS;

ADULT; AGE OF ONSET; AGED; AGING; ATROPHY; BRAIN; BRAIN CHEMISTRY; CAUDATE NUCLEUS; DISEASE PROGRESSION; EDUCATIONAL STATUS; ELECTROMAGNETIC FIELDS; FEMALE; HETEROZYGOTE; HUMANS; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PUTAMEN; SEX CHARACTERISTICS;

EID: 84861184989     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.03.056     Document Type: Article

References (43)

1. Aquino D., Bizzi A., Grisoli M., Garavaglia B., Bruzzone M.G., Nardocci N., Savoiardo M., Chiapparini L. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 2009, 252:165-172.
2. Aylward E.H., Li Q., Stine O.C., Ranen N., Sherr M., Barta P.E., Bylsma F.W., Pearlson G.D., Ross C.A. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology 1997, 48:394-399.
3. Aylward E.H., Codori A.M., Rosenblatt A., Sherr M., Brandt J., Stine O.C., Barta P.E., Pearlson G.D., Ross C.A. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov. Disord. 2000, 15:552-560.
4. Bartzokis G., Tishler T.A. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntington's disease. Cell. Mol. Biol. 2000, 46:821-833.
5. Bartzokis G., Cummings J., Perlman S., Hance D.B., Mintz J. Increased basal ganglia iron levels in Huntington disease. Arch. Neurol. 1999, 56:569-574.
6. Bartzokis G., Sultzer D., Lu P.H., Nuechterlein K.H., Mintz J., Cummings J.L. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol. Aging 2004, 25:843-851.
7. Bartzokis G., Tishler T.A., Shin I.S., Lu P.H., Cummings J.L. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann. N. Y. Acad. Sci. 2004, 1012:224-236.
8. Bartzokis G., Lu P.H., Tishler T.A., Fong S.M., Oluwadara B., Finn J.P., Huang D., Bordelon Y., Mintz J., Perlman S. Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem. Res. 2007, 32:1655-1664.
9. Berg D., Youdim M.B. Role of iron in neurodegenerative disorders. Top. Magn. Reson. Imaging 2006, 17:5-17.
10. Brass S.D., Chen N.K., Mulkern R.V., Bakshi R. Magnetic resonance imaging of iron deposition in neurological disorders. Top. Magn. Reson. Imaging 2006, 17:31-40.
11. Chen J.C., Hardy P.A., Kucharczyk W., Clauberg M., Joshi J.G., Vourlas A., Dhar M., Henkelman R.M. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am. J. Neuroradiol. 1993, 14:275-281.
12. Dexter D.T., Carayon A., Javoyagid F., Agid Y., Wells F.R., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. Alterations in the levels of iron, ferritin and other trace-metals in Parkinson's-Disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991, 114:1953-1975.
13. Drayer B., Burger P., Darwin R., Riederer S., Herfkens R., Johnson G.A. MRI of brain iron. AJR Am. J. Roentgenol. 1986, 147:103-110.
14. Ge Y., Jensen J.H., Lu H., Helpern J.A., Miles L., Inglese M., Babb J.S., Herbert J., Grossman R.I. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am. J. Neuroradiol. 2007, 28(9):1639-1644.
15. Gelman N., Gorell J.M., Barker P.B., Savage R.M., Spickler E.M., Windham J.P., Knight R.A. MR imaging of human brain at 3.0T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999, 210:759-767.
16. Graham J.M., Paley M.N., Grunewald R.A., Hoggard N., Griffiths P.D. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 2000, 123(Pt 12):2423-2431.
17. Haacke E.M., Xu Y., Cheng Y.C., Reichenbach J.R. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 2004, 52:612-618.
18. Haacke E.M., Chengb N.Y.C., House M.J., Liu Q., Neelavalli J., Ogg R.J., Khan A., Ayaz M., Kirsch W., Obenaus A. Imaging iron stores in the brain using magnetic resonance imaging. Magn. Reson. Imaging 2005, 23:1-25.
19. Haacke E.M., Miao Y.W., Liu M.J., Habib C.A., Katkuri Y., Liu T., Yang Z.H., Lang Z.J., Hu J.N., Wu J.L. Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults. J. Magn. Reson. Imaging 2010, 32:561-576.
20. Haller S., Bartsch A., Nguyen D., Rodriguez C., Emch J., Gold G., Lovblad K.O., Giannakopoulos P. Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibility-weighted MR imaging assessment. Radiology 2010, 257(3):764-773.
21. Hallgren B., Sourander P. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 1958, 3:41-51.
22. Ischiropoulos H., Beckman J.S. Oxidative stress and nitration in neurodegeneration: cause, effect, or association?. J. Clin. Invest. 2003, 111:163-169.
23. Jensen J.H., Chandra R., Ramani A., Lu H., Johnson G., Lee S.P., Kaczynski K., Helpern J.A. Magnetic field correlation imaging. Magn. Reson. Med. 2006, 55:1350-1361.
24. Jensen J.H., Szulc K., Hu C., Ramani A., Lu H., Xuan L., Falangola M.F., Chandra R., Knopp E.A., Schenck J., Zimmerman E.A., Helpern J.A. Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magn. Reson. Med. 2009, 61:481-485.
25. Jurgens C.K., Jasinschi R., Ekin A., Witjes-Ane M.N., Middelkoop H., van der Grond J., Roos R. MRI T2 hypointensities in basal ganglia of premanifest Huntington's disease. PLoS Curr. 2010, 2.
26. Langbehn D.R., Brinkman R.R., Falush D., Paulsen J.S., Hayden M.R. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin. Genet. 2004, 65:267-277.
27. Patenaude B., Smith S.M., Kennedy D.N., Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011, 56:907-922.
28. Paulsen J.S., Magnotta V.A., Mikos A.E., Paulson H.L., Penziner E., Andreasen N.C., Nopoulos P.C. Brain structure in preclinical Huntington's disease. Biol. Psychiatry 2006, 59:57-63.
29. Penney J.B., Vonsattel J.P., MacDonald M.E., Gusella J.F., Myers R.H. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann. Neurol. 1997, 41:689-692.
30. Raz E., Jensen J.H., Ge Y., Babb J.S., Miles L., Reaume J., Grossman R.I., Inglese M. Brain iron quantification in mild traumatic brain injury: a magnetic field correlation study. AJNR Am. J. Neuroradiol. 2011, 32(10):1851-1856. (2011 Nov-Dec).
31. Roos R.A.C., Bots G.T.A.M. Nuclear-membrane indentations in Huntington's-Chorea. J. Neurol. Sci. 1983, 61:37-47.
32. Roos R.A.C., Pruyt J.F.M., Devries J., Bots G.T. Neuronal distribution in the putamen in Huntington's-Disease. J. Neurol. Neurosurg. Psychiatry 1985, 48:422-425.
33. Schenck J.F., Zimmerman E.A. High-field magnetic resonance imaging of brain iron: birth of a biomarker?. NMR Biomed. 2004, 17:433-445.
34. Shoulson I., Fahn S. Huntington disease: clinical care and evaluation. Neurology 1979, 29:1-3.
35. Simmons D.A., Casale M., Alcon B., Pham N., Narayan N., Lynch G. Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia 2007, 55:1074-1084.
36. Stankiewicz J.M., Brass S.D. Role of iron in neurotoxicity: a cause for concern in the elderly?. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12:22-29.
37. Tabrizi S.J., Langbehn D.R., Leavitt B.R., Roos R.A., Durr A., Craufurd D., Kennard C., Hicks S.L., Fox N.C., Scahill R.I., Borowsky B., Tobin A.J., Rosas H.D., Johnson H., Reilmann R., Landwehrmeyer B., Stout J.C. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009, 8:791-801.
38. van den Bogaard S.J., Dumas E.M., Acharya T.P., Johnson H., Langbehn D.R., Scahill R.I., Tabrizi S.J., van Buchem M.A., van der Grond J., Roos R.A. Early atrophy of pallidum and accumbens nucleus in Huntington's disease. J. Neurol. 2010, 258:412-420.
39. Vonsattel J.P.G., DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 1998, 57:369-384.
40. Vymazal J., Klempir J., Jech R., Zidovska J., Syka M., Ruzicka E., Roth J. MR relaxometry in Huntington's disease: correlation between imaging, genetic and clinical parameters. J. Neurol. Sci. 2007, 263:20-25.
41. Wu Z., Mittal S., Kish K., Yu Y., Hu J., Haacke E.M. Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J. Magn. Reson. Imaging 2009, 29:177-182.
42. Xu X., Wang Q., Zhang M. Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. Neuroimage 2008, 40:35-42.
43. Zecca L., Youdim M.B.H., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 2004, 5:863-873.